Heron (Shanghai) Pharmaceutical Science and Technology Co., Ltd.

Founded in 2013, Heron Pharma is a pharmaceutical company adhering to an innovation-driven and product differentiation strategy. lt possesses world-leading research and development technology for active vitamin D derivatives, NCEs and first generics. The bulk production of active vitamin D derivative drugs can be provided over the world, including Alfacalcidol, Calcipotriol, Calcifediol, Calcitriol, Eldecalcitol, Doxercalciferol, Maxacalcitol, Paricalcitol, Tacalcitol, etc.
Over the past decade, 8 FDFs have been successfully commercialized in China, including the first generics of Tacalcitol Ointment and Regadenoson Injection. And 2 products Calcitriol Soft Capsules and Ketorolac Tromethamine Injection have been involved in the centralized purchasing of the National Healthcare Security Bureau.